Jump to content

Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC): Voluntary Lot Withdrawals - Due to Increased Reports of Allergic/Hypersensitivity Reactions

FDA Recalls

By FDA Recalls
March 11 in Recalls

Share

Recommended Posts

FDA Recalls

Newbie

FDA Recalls

Posted March 11

- Share

Posted March 11

As a precautionary measure, the following lots of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) have been voluntarily withdrawn by the manufacturers due to a higher rate of allergic/hypersensitivity type reactions, some of which were considered medically significant.

View the full article

Quote

Link to comment

Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest

Reply to this topic...

× Pasted as rich text. Paste as plain text instead

Only 75 emoji are allowed.

× Your link has been automatically embedded. Display as a link instead

× Your previous content has been restored. Clear editor

× You cannot paste images directly. Upload or insert images from URL.

Insert image from URL

×

Share

Go to topic listing

×

BMET Galaxy (Home)
Forums
Events
Clubs
Leaderboard
Activity
- Back
- All Activity
- Search
- Our Picks

×

Create New...